L. Simonsen, The global impact of influenza on morbidity and mortality, Vaccine, vol.17, pp.3-10, 1999.
DOI : 10.1016/S0264-410X(99)00099-7

C. Wong, L. Yang, and K. Chan, Influenza-Associated Hospitalization in a Subtropical City, PLoS Medicine, vol.23, issue.4, p.121, 2006.
DOI : 10.1371/journal.pmed.0030121.st002

H. Izurieta, W. Thompson, and P. Kramarz, Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children, New England Journal of Medicine, vol.342, issue.4, pp.232-339, 2000.
DOI : 10.1056/NEJM200001273420402

K. Neuzil, B. Mellen, P. Wright, E. Mitchel, and M. Griffin, The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in Children, New England Journal of Medicine, vol.342, issue.4, pp.225-231, 2000.
DOI : 10.1056/NEJM200001273420401

S. Chiu, Y. Lau, K. Chan, W. Wong, and J. Peiris, Influenza-Related Hospitalizations among Children in Hong Kong, New England Journal of Medicine, vol.347, issue.26, pp.2097-2103, 2001.
DOI : 10.1056/NEJMoa020546

R. Redfield, B. Innis, R. Scott, H. Cannon, and W. Bancroft, Clinical Evaluation of Low-Dose Intradermally Administered Hepatitis B Virus Vaccine, JAMA, vol.254, issue.22, pp.3203-3206, 1985.
DOI : 10.1001/jama.1985.03360220069031

J. Bryan, M. Sjogren, P. Perine, and I. Legters, Low-Dose Intradermal and Intramuscular Vaccination against Hepatitis B, Clinical Infectious Diseases, vol.14, issue.3, pp.697-707, 1992.
DOI : 10.1093/clinids/14.3.697
URL : http://cid.oxfordjournals.org/cgi/content/short/14/3/697

A. Sabchareon, P. Chantavanich, and S. Pasuralertsakul, Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine, The Pediatric Infectious Disease Journal, vol.17, issue.11, pp.1001-1007, 1998.
DOI : 10.1097/00006454-199811000-00007

T. Weller, F. Cheever, and J. Enders, Immunologic Reactions Following the Intradermal Inoculation of Influenza A and B Vaccine., Experimental Biology and Medicine, vol.67, issue.1, pp.96-101, 1948.
DOI : 10.3181/00379727-67-16216

J. Quilligan, . Jr, P. Salgado, and A. B. , Influenza vaccination in children, Am J Dis Child, vol.101, pp.593-601, 1961.

M. Klein and N. Huang, The response of infants and children to Asian influenza vaccine administered by intradermal and subcutaneous routes, The Journal of Pediatrics, vol.58, issue.3, pp.312-314, 1961.
DOI : 10.1016/S0022-3476(61)80260-6

E. Mortimer and . Jr, Intradermal injections of influenza vaccines, Pediatrics, vol.42, p.875, 1968.

M. Marks and J. Eller, Intradermal influenza immunization. Experience with Hong Kong vaccine, Am Rev Respir Dis, vol.103, pp.579-581, 1971.

H. Brown, J. Kasel, D. Freeman, L. Moise, N. Grose et al., The Immunizing Effect of Influenza A/New Jersey/76 (Hsw1N1) Virus Vaccine Administered Intradermally and Intramuscularly to Adults, Journal of Infectious Diseases, vol.136, issue.Supplement 3, pp.466-471, 1977.
DOI : 10.1093/infdis/136.Supplement_3.S466

R. Belshe, F. Newman, and J. Cannon, Serum Antibody Responses after Intradermal Vaccination against Influenza, New England Journal of Medicine, vol.351, issue.22, pp.2286-2294, 2004.
DOI : 10.1056/NEJMoa043555

R. Kenney, S. Frech, L. Muenz, C. Villar, and G. Glenn, Dose Sparing with Intradermal Injection of Influenza Vaccine, New England Journal of Medicine, vol.351, issue.22, pp.2295-2301, 2004.
DOI : 10.1056/NEJMoa043540

J. Salk, Simplified procedure for titrating hemagglutinating capacity of influenza virus and the corresponding antibody

D. Mitchell, F. Ruben, and S. Gravenstein, IMMUNOGENICITY AND SAFETY OF INACTIVATED INFLUENZA VIRUS VACCINE IN YOUNG CHILDREN IN 2003???2004, The Pediatric Infectious Disease Journal, vol.24, issue.10, pp.925-927, 2003.
DOI : 10.1097/01.inf.0000180978.66362.d9

M. Bhushan, M. Cumberbatch, R. Dearman, S. Andrew, I. Kimber et al., Tumour necrosis factor-??-induced migration of human Langerhans cells: the influence of ageing, British Journal of Dermatology, vol.94, issue.Suppl. 35, pp.32-40, 2002.
DOI : 10.1046/j.1365-2133.2002.04549.x

W. Beyer, A. Palache, G. Luchters, J. Nauta, and A. Osterhaus, Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?, Virus Research, vol.103, issue.1-2, pp.125-132, 2004.
DOI : 10.1016/j.virusres.2004.02.024

P. Degano, J. Schneider, G. Hannan, S. Gilbert, and A. Hill, Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models, Vaccine, vol.18, issue.7-8, pp.623-632, 2000.
DOI : 10.1016/S0264-410X(99)00278-9

L. Jackson, G. Austin, and R. Chen, Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors, Vaccine, vol.19, issue.32, pp.4703-4709, 2001.
DOI : 10.1016/S0264-410X(01)00225-0

D. Chen, M. Burger, and Q. Chu, Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity, Virus Research, vol.103, issue.1-2, pp.147-153, 2004.
DOI : 10.1016/j.virusres.2004.02.027

K. Peachman, M. Rao, and C. Alving, Immunization with DNA through the skin, Methods, vol.31, issue.3, pp.232-242, 2003.
DOI : 10.1016/S1046-2023(03)00137-3

I. Stephenson, K. Nicholson, J. Wood, M. Zambon, and J. Katz, Confronting the avian influenza threat: vaccine development for a potential pandemic, The Lancet Infectious Diseases, vol.4, issue.8, pp.490-508, 2004.
DOI : 10.1016/S1473-3099(04)01105-3

J. Bresson, C. Perronne, and O. Launay, Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial, The Lancet, vol.367, issue.9523, pp.1657-1664, 1194.
DOI : 10.1016/S0140-6736(06)68656-X

S. Patel, R. Atmar, H. Sahly, T. Cate, and W. Keitel, Randomized , open-label, phase 1 clinical trial comparing the safety, reactogenicity, and immunogenicity of booster immunization with inactivated influenza A/H5N1 vaccine administered by the intradermal (ID) or the intramuscular IIM) route among healthy adults, Presented at: IDSA annual meeting, pp.12-15, 2006.